INVESTOR RELATIONS

At Provectus Therapeutics, we are committed to transforming the landscape of personalised oncology treatments through innovative research and development. Our strategic investments and robust R&D initiatives have positioned us at the forefront of cancer research advancements.

As of June 2024, we have secured $1.5 million USD in funding dedicated to product development and retrospective clinical studies. We invite you to explore the unique opportunities to partner with us as we continue to drive breakthroughs in cancer treatment and improve patient outcomes worldwide.

Join us on our journey to redefine the future of cancer treatment.